Myongji Hospital said Wednesday that it would develop a mobile artificial intelligence-based computerized tomography that detects Covid-19 virus, in a three-party joint project with Vatech and Phenomx.
|Myongji Hospital Chairman Lee Wang-jun (center), Vatech CEO Hyun Jeong-hoon (left), and Phenomx CEO Kim Han-seok hold the trilateral agreement, at Myongji Hospital in Goyang, Gyeonggi Province, on Tuesday.|
The three organizations have agreed to cooperate in research and technology exchange related to the development project through their respective know-how.
Specifically, Myongji Hospital has know-how on research experience and clinical trial infrastructure obtained from treating Covid-19 patients, Vatech has low-dose, high-resolution mobile CT-related technology capable of specialized diagnosis of viral pneumonia, and Phenomx has unique AI artificial intelligence service that can increase speed and accuracy in diagnosing Covid-19.
Myongji Hospital will install Vatech’s mobile CT and begin IRB (institutional review board)-based research and field tests by combining the lung CT data with Phenomx’s AI algorithm optimization technology.
Earlier, Myongji Hospital and Phenomx cooperated in launching Phenochest-AI, an AI service for Covid-19 diagnosis through image data, in the U.S. market.
“Mobile CT and AI solutions are important tasks included in the government-backed Covid-19 treatment and vaccine development support organization’s 11 core medical device that needs to be locally developed,” Myongji Hospital Chairman Lee Wang-jun said. “We expect to see visible results soon while providing another milestone for Covid-19 research.”
<© Korea Biomedical Review, All rights reserved.>